Inflammation, genes, and lifestyle converge to shape heart disease risk

Researchers analyzing nearly half a million UK adults have traced a path from inherited genes and daily habits straight into the heart itself, revealing how chronic inflammation reshapes the organ's structure and function in ways that predict serious trouble ahead.

The study, published in the European Journal of Preventive Cardiology, examined blood biomarkers, genetic profiles, cardiac imaging, and health records from up to 488,079 participants in the UK Biobank. What emerged was a picture of convergence: the inflammation marker GlycA—a measure of chronic low-grade inflammation—correlated with smaller heart chambers, thicker heart walls, reduced pumping efficiency, and a 43 percent higher risk of major adverse cardiovascular events in people with the highest inflammation levels compared to those with the lowest.

The inflammatory signature itself appears to be written in specific proteins. Researchers identified 63 inflammatory proteins that statistically explained the link between chronic inflammation and heart attacks, strokes, and heart failure. The most significant of these belonged to signaling pathways involving tumor necrosis factor and interleukin-6—molecules that, when overactive, seem to remodel the heart in harmful ways. Other key players included interleukin-1 and hepatocyte growth factor, which mediated different aspects of the structural changes: how much blood the heart's main chamber could hold, how thick its walls became.

But inflammation does not arise in isolation. The researchers identified which environmental and lifestyle factors most strongly drove it. Trunk fat mass—the visceral fat around the organs—showed the strongest association with elevated inflammation, followed closely by current smoking, psychological distress, and low socioeconomic status. On the protective side, higher socioeconomic status, regular physical activity, and a healthier diet correlated with lower inflammation levels. The pattern held across 177 environmental and body-composition factors analyzed.

What distinguished this study was its focus on interaction: how genetic susceptibility modified the relationship between these exposures and inflammation. The researchers identified 49 gene-environment interactions that significantly altered the association between inflammation levels and cardiovascular risk. Socioeconomic status, mental health, and physical activity emerged as the strongest categories where genetic background appeared to amplify or dampen the effect of environmental stressors. In other words, two people exposed to the same risk factor—say, smoking—might experience different inflammatory responses depending on their genetic makeup.

The cardiac changes themselves tell a specific story. Higher inflammation correlated with reduced stroke volume, the amount of blood pumped with each heartbeat, and a modest increase in resting heart rate—possibly a compensatory response to that reduced output. The heart walls thickened. The chambers shrank. Diastolic function, the heart's ability to relax and refill between beats, declined. Yet the upper chambers did not enlarge, suggesting the filling pressure remained relatively normal, at least in this snapshot.

The researchers acknowledged important limitations. The UK Biobank participants were predominantly White Europeans with better health and socioeconomic status than the general UK population, which may limit how well these findings apply to other ethnic groups or higher-risk populations. Environmental exposures were measured with varying precision. The mediation analyses, which traced inflammation's role in the pathway from risk factors to heart disease, were cross-sectional rather than longitudinal, meaning they could not definitively establish cause and effect or rule out reverse causation.

Still, the findings point toward potential interventions. The inflammatory biomarkers identified—particularly those in the interleukin-1 and tumor necrosis factor families—could become therapeutic targets. Future work will need to test whether combining genetic risk assessment with inflammatory biomarker measurements could identify which individuals are most vulnerable to inflammatory stressors and therefore at highest risk of cardiovascular events. The convergence of genes, inflammation, and environment appears to be where the real story of heart disease risk unfolds.